Page last updated: 2024-11-02

pilsicainide and Heart Diseases

pilsicainide has been researched along with Heart Diseases in 2 studies

pilsicainide: structure given in first source
pilsicainide : A secondary carboxamide resulting from the formal condensation of the amino group of 2,6-dimethylaniline with the carboxy group of (tetrahydro-1H-pyrrolizin-7a(5H)-yl)acetic acid. It is a sodium channel blocker which is used as an antiarrhythmic drug for the management of atrial tachyarrhythmias in Japan.

Heart Diseases: Pathological conditions involving the HEART including its structural and functional abnormalities.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aiba, T1
Shimizu, W1
Hidaka, I1
Uemura, K1
Noda, T1
Zheng, C1
Kamiya, A1
Inagaki, M1
Sugimachi, M1
Sunagawa, K1
Ueyama, T1
Shimizu, A1
Yamagata, T1
Esato, M1
Ohmura, M1
Yoshiga, Y1
Kanemoto, M1
Kametani, R1
Sawa, A1
Suzuki, S1
Sugi, N1
Matsuzaki, M1

Trials

1 trial available for pilsicainide and Heart Diseases

ArticleYear
Different effect of the pure Na+ channel-blocker pilsicainide on the ST-segment response in the right precordial leads in patients with normal left ventricular function.
    Circulation journal : official journal of the Japanese Circulation Society, 2007, Volume: 71, Issue:1

    Topics: Adult; Aged; Algorithms; Brugada Syndrome; Electrocardiography; Female; Heart Diseases; Humans; Lido

2007

Other Studies

1 other study available for pilsicainide and Heart Diseases

ArticleYear
Cellular basis for trigger and maintenance of ventricular fibrillation in the Brugada syndrome model: high-resolution optical mapping study.
    Journal of the American College of Cardiology, 2006, May-16, Volume: 47, Issue:10

    Topics: Action Potentials; Animals; Cardiovascular Agents; Disease Models, Animal; Dogs; Electrocardiography

2006